Literature DB >> 2017637

Natural history of recurrent urinary tract infections in women.

W E Stamm1, M McKevitt, P L Roberts, N J White.   

Abstract

To evaluate the natural history of uncomplicated urinary tract infections in women, we observed 51 infection-prone women in a standardized fashion for a median of 9 years. During intervals when patients were not receiving antimicrobial prophylaxis, infections occurred at an average rate of 2.6 per patient-year, but the rate varied widely from patient to patient (range 0.3-7.6 episodes per year). Seventy-three percent of the observed episodes were symptomatic, with an 18:1 ratio of cystitis to pyelonephritis episodes. Infectious episodes were strikingly clustered, and rates of infection decreased in the winter months. Antimicrobial prophylaxis was highly effective in preventing acute cystitis, asymptomatic bacteriuria, and acute pyelonephritis, even when used for as long as 5 years. The proportions of infecting strains resistant in vitro to ampicillin (19%-32%) and nitrofurantoin (5%-18%) were unchanged over the 15-year observation period, while resistance to trimethoprim-sulfamethoxazole increased in the last 5 years of the study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017637     DOI: 10.1093/clinids/13.1.77

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  43 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Diagnosis and management of urinary tract infection in adults.

Authors:  M E Wilkie; M K Almond; F P Marsh
Journal:  BMJ       Date:  1992-11-07

3.  Prophylaxis: recurrent urinary tract infection in women.

Authors:  L E Nicolle
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 4.  The Vaginal Microbiota and Urinary Tract Infection.

Authors:  Ann E Stapleton
Journal:  Microbiol Spectr       Date:  2016-12

Review 5.  [Treatment and prophylaxis of recurrent urinary tract infections].

Authors:  B Banas; B K Krämer
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

6.  Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

Authors:  Ann E Stapleton; Melissa Au-Yeung; Thomas M Hooton; David N Fredricks; Pacita L Roberts; Christopher A Czaja; Yuliya Yarova-Yarovaya; Tina Fiedler; Marsha Cox; Walter E Stamm
Journal:  Clin Infect Dis       Date:  2011-04-14       Impact factor: 9.079

7.  Warmer weather as a risk factor for hospitalisations due to urinary tract infections.

Authors:  J E Simmering; J E Cavanaugh; L A Polgreen; P M Polgreen
Journal:  Epidemiol Infect       Date:  2018-01-08       Impact factor: 2.451

8.  Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections.

Authors:  W H Lin; C Y Kao; D C Yang; C C Tseng; A B Wu; C H Teng; M C Wang; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

9.  Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Authors:  Matt S Conover; Ségolène Ruer; Joemar Taganna; Vasilios Kalas; Henri De Greve; Jerome S Pinkner; Karen W Dodson; Han Remaut; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2016-09-22       Impact factor: 21.023

10.  Highly resistant metabolically deficient dwarf mutant of Escherichia coli is the cause of a chronic urinary tract infection.

Authors:  Konrad Trülzsch; Harald Hoffmann; Christiane Keller; Sören Schubert; Lutz Bader; Jürgen Heesemann; Andreas Roggenkamp
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.